National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010

H.R.914-Physician Workforce Enhancement Act of 2009 H.R.1086-Help, Efficient, Accessible, Low Cost, Timely Healthcare Act of 2009 H.R.1188-Access to Emergency Medical Services Act of 2009 H.R.1253-Health Insurance Restrictions and Limitations Clarification Act of 2009 H.R.1384-To amend part B of title XVIII of the Social Security Act to remove limiting charges under the Medicare Program for non-participating physicians with beneficiary notice and to preempt State laws that prohibit balance billing H.R.1386-Pay for all your Undocumented Procedures (PAY UP!) Act of 2009 H.R.1468-Medical Justice Act of 2009 H.R.1586/P.L.111-226, FAA Air Transportation Modernization and Safety Improvement Act (Title II) H.R.1639-Border Health Care Relief Act of 2009 H.R.1678-Mitigating the Impact of Uncompensated Service and Time Act of 2009 H.R.1796-Residential Carbon Monoxide Poisoning Prevention Act H.R.1998-Health Care Safety Net Enhancement Act of 2009 H.R.3199-Emergency Medic Transition (EMT) Act of 2009 H.R.3360/P.L.111-332-Cruise Vessel Security and Safety Act of 2010 H.R.3590/P.L.111-148-Patient Protection and Affordable Care Act H.R.4994/P.L.111-309-Medicare and Medicaid Extenders Act of 2010 H.R.5710-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 H.R.5712/P.L.111-286-Physician Payment and Therapy Relief Act of 2010 H.R.5950-Improving Access to Medicare Coverage Act of 2010 H.R.6306-Critical Care Assessment and Improvement Act of 2010 S.468-Access to Emergency Medical Services Act of 2009 S.1216-Residential Carbon Monoxide Poisoning Prevention Act S.1681-Health Insurance Industry Antitrust Enforcement Act of 2009 S.3575-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010

Client expense: $550,718 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 3590 Patient Protection and Affordable Care Act, Pub. Law No: 111-148 H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act H.R. 4872, The Health Care and Education Affordability Reconciliation Act of 2010 H.R. 5808, To amend the Patient Protection and Affordable Care Act to establish a public health insurance option. Nondiscrimination language regarding paraprofessionals H.R. 5295, Healthcare Truth and Transparency Act: Healthcare Provider Transparency, Healthcare Provider Misrepresentation H.R. 756, National Pain Care Policy Act, S.660, National Pain Care Policy Act DEA E-Prescribing DEA Propofol Comparative Effectiveness Research Hospital Acquired Infections HITECH Implemenation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use Data Registry Funding HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Risk Evaluation and Mitigation Strategies Physician Antitrust Relief Physician Workforce Issues Medical Liability Reform FDA Safe Use Initiative FDA Operating Room Fires FDA ACTION Initiative FDA Propofol Shortage FDA Scheduling of Propofol FDA Sentinel Non-Anesthesia Provider Use of Propofol Prescription Drug User Fee Act Deep sedation NASPER Funding; controlled substance abuse, misuse and diversion Required Physician Supervision of Nurse Anesthetists, Nurse error rates State Exchanges pursuant to PPACA Patient Safety Initiatives FDA SEDASYS FDA Sedation Products Request for Assistance Interventional Pain OSHA Resident Hours regulation

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Federal Trade Commission (FTC), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Occupational Safety & Health Administration (OSHA), Office of Management & Budget (OMB), SENATE

**see addendum page Importation of prescription drugs (S.525/H.R. 1298) RX Pedigree Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923) Pharmacy Benefit Management Issues (H.R. 4489) Drug Disposal (S. 3397, H.R. 5809) PDMP Funding/NASPER reauthorization (H.R. 5710) Drug Safety Enhancement Act (H.R. 6543)

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2010 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 Under Line 17: We would like to include the Office of National Drug Control Policy (ONDCP) HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act S 80 - Pharmaceutical Market Access Act of 2009 HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA-2010-N-0001) Third Annual Sentinel Initiative Public Workshop (Docket Number: FDA-2010-N-0128) Prescription Drug User Fee Act; Reopening of the Comment Period (Docket Number: FRL-9197-7) EPA Best Management Practices for Unused Pharmaceuticals at Health Care Facilities (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: DEA-338) Schedules of Controlled Substances: Placement of Propofol Into Schedule IV; Proposed Rule (Docket Number: FDA-2010-N-0273) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Current Good Manufacturing Practice Quality System Regulations (Docket No. FDA-2010-N-0344) Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Testing Communications on Medical Devices and Radiation-Emitting Products (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: FDA-2010-N-0477) Approval Pathway for Biosimilar and Interchangeable Biological Products; Public Hearing; Request for Comments (Docket Number: FDA2010N0486) Safe Use Initiative; Public Workshop; Request for Comments (RIN 0720AB45) DoD Civilian Health and Medical Program of the Uniformed Services (CHAMPUS)/ TRICARE: Inclusion of TRICARE Retail Pharmacy Program in Federal Procurement of Pharmaceuticals (Docket Number: DEA316N) Procedures for the Surrender of Unwanted Controlled Substances by Ultimate Users; Notice of Meeting (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies FDA Draft Guidance for Industry and Food and Drug Administration Staff on Dear Health Care Provider Letters: Improving Communication of Important Safety Information Concept Standardizing REMS programs, components and development of a potential tiered REMS System Concept 2010 National Drug Control Strategy (ONDCP)

Client expense: $240,240 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Environmental Protection Agency (EPA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Natl Institutes of Health (NIH), SENATE, White House Office

Importation of prescription drugs (S. 525/H.R. 1298); Drug Safety Enhancement Act (H.R. 6543); Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues (H.R. 4489); Drug Disposal (S. 3397, H.R. 5809); PDMP Funding/NASPER Reauthorization (H.R. 5710)

Client expense: $214,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

H.R. 1427, Promoting Innovations and Lifesaving Medicines Act; H.R. 3590, Patient Protection and Affordable Care Act; H.R. 4872, The Health Care and Education Reconciliation Act of 2010. S. 525, S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009. Issues pertaining to: prescription drug importation, comparative effectiveness, follow-on biologics, Medicare prescription drug coverage, Medicaid rebates. H.R. 444, 340B Program Improvement and Integrity Act: 340B program issues. H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009: importation. H.R. 2502, Comparative Effectiveness Research Act of 2009: comparative effectiveness. H.R. 2824, Doctor-Patient Relationship and Research Protection Act: comparative effectiveness. H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010: controlled substance monitoring. H.R. 5809, Safe Drug Disposal Act of 2010: disposal of controlled substances. S. 1203, Grow Research Opportunities with Taxcredits' Help Act: R&D tax credit provisions. S. 1213, Patient-Centered Outcomes Research Act of 2009: comparative effectiveness. S. 1679, Affordable Health Choices Act: 340B program issues, importation, and other health reform implementation issues. S. 3397, Secure and Responsible Drug Disposal Act of 2010: disposal of controlled substances General FDA advocacy.

Client expense: Not reported · Firm income: $60,000

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R.1173, The Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R.1166, the E-fencing Enforcement Act of 2008, as related to the prosecution of organized theft. H.R.4011, Organized Retail Crime Prevention and Enforcement Act of 2009, as related to the prosecution of organized theft. S.470, Combating Organized Retail Crime Act of 2009, as related to the prosecution of organized theft. H.R.5710, The National All Schedules Electronic Reporting Reauthorization Act. S.3397, Secure and Responsible Drug Disposal Act. H.R.1191, Safe Drug Disposal Act. H.R.5932, Organized Retail Theft Investigation and Prosecution Act. S.3575, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010.

Client expense: $360,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

Legislation concerning privacy regarding inadvertent disclosure of protected health information; HR 5777 (Rush Privacy bill); S. 3742-Data Security and Breach Notification Act of 2010. Legislation concerning pharmacy benefit management issues, drug safety and tracking drug suppliers; S.3397, HR 1359, HR 5710. (et al., HR 4199, HR 5234, HR 4489, HR 4213).

Client expense: Not reported · Firm income: $30,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 422, Heart Disease Education, Analysis Research, and Treatment for Women Act: R&D tax credit provisions H.R. 444, 340B Program Improvement and Integrity Act: 340B program issues H.R. 1032, Heart Disease Education, Analysis Research, and Treatment for Women Act: clinical trial data reporting issues H.R. 1298, Pharmaceutical Market Access and Drug Safety Act of 2009: importation H.R. 2502, Comparative Effectiveness Research Act of 2009: comparative effectiveness H.R. 2824, Doctor-Patient Relationship and Research Protection Act: comparative effectiveness H.R. 3590, Patient Protection and Affordable Care Act: comparative effectiveness, 340B program issues, drug labeling, access to clinical trials, health reform fee, Independent Payment Advisory Board (IPAB) and other health reform implementation issues H.R. 4213, American Jobs and Closing Tax Loopholes Act of 2010: 340B program and average manufacturer price (AMP) issues H.R. 4489, FEHBP Prescription Drug Integrity, Transparency, and Cost Savings Act: transparency of drug pricing H.R. 4872, Health Care and Education Reconciliation Act of 2010: 340B program and health reform fee issues H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010: controlled substance monitoring H.R. 5809, Safe Drug Disposal Act of 2010: disposal of controlled substances S. 525, Pharmaceutical Market Access and Drug Safety Act of 2009: importation S. 1203, Grow Research Opportunities With Taxcredits' Help Act: R&D tax credit provisions S. 1213, Patient-Centered Outcomes Research Act of 2009: comparative effectiveness S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009: importation S. 1679, Affordable Health Choices Act: 340B program issues, importation, and other health reform implementation issues S. 3397, Secure and Responsible Drug Disposal Act of 2010: disposal of controlled substances General FDA advocacy

Client expense: $5,180,000 · Firm income: Not reported

Government targets: Agency for Healthcare Research & Quality (AHRQ), Centers For Medicare and Medicaid Services (CMS), Commerce, Dept of (DOC), Congressional Budget Office (CBO), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Health Resources & Services Administration (HRSA), Internal Revenue Service (IRS), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), Patent & Trademark Office (PTO), SENATE, State, Dept of (DOS), U.S. Trade Representative (USTR), White House Office

Pharmacy Issues related to drug safety and the tracking of drug suppliers. S. 3397 Secure and Responsible Drug Disposal Act of 2010 HR 1359 Secure and Responsible Drug Disposal Act of 2009 HR 5710 National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010

Client expense: $2,550,000 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010, all provisions S. 3668, Medical-Legal Partnership for Health Act, all provisions H.R. 5961, Medical-Legal Partnership for Health Act, all provisions Patient Protection and Affordable Care Act of 2010 - repeal of expanded Form 1099 reporting (Section 9006) Patient Protection and Affordable Care Act of 2010 and reconciliation, provisions on health care reform Patient Protection and Affordable Care Act of 2010, Quality Measure Development HITECH Act implementation/meaningful use American Recovery and Reinvestment Act of 2009, provisions on physicians employed by community health centers Physician Re-entry to Medical Profession Independent Payment Advisory Board (IPAB) Post Traumatic Stress Disorder/Traumatic Brain Injury FTC Red Flag Rule Childhood Obesity Uncompensated Care Antipersonnel Landmines Patient-Centered Outcomes Research Institute (PCORI) Board of Governors Advisory Group on Prevention, Health Promotion, and Integrative and Public Health Regulation of resident physician work hours Stand for Quality Coalition Delivery Reform Health Insurance Reform Antibiotic Resistance and Animal Agriculture Climate Change Dispensing of Methadone in Opioid Treatment Programs Self-referral of imaging services Health sector portion of US-Russia Bilateral Presidential Commission agenda

Client expense: $2,250,000 · Firm income: Not reported

Government targets: Centers For Disease Control & Prevention (CDC), Centers For Medicare and Medicaid Services (CMS), Executive Office of the President (EOP), Federal Trade Commission (FTC), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Medicare Payment Advisory Commission (MedPAC), Occupational Safety & Health Administration (OSHA), SENATE, Treasury, Dept of, White House Office

H.R.914-Physician Workforce Enhancement Act of 2009 H.R.1086-Help, Efficient, Accessible, Low Cost, Timely Healthcare Act of 2009 H.R.1188-Access to Emergency Medical Services Act of 2009 H.R.1253-Health Insurance Restrictions and Limitations Clarification Act of 2009 H.R.1384-To amend part B of title XVIII of the Social Security Act to remove limiting charges under the Medicare Program for non-participating physicians with beneficiary notice and to preempt State laws that prohibit balance billing H.R.1386-Pay for all your Undocumented Procedures (PAY UP!) Act of 2009 H.R.1468-Medical Justice Act of 2009 H.R.1586/P.L.111-226, FAA Air Transportation Modernization and Safety Improvement Act (Title II) H.R.1639-Border Health Care Relief Act of 2009 H.R.1678-Mitigating the Impact of Uncompensated Service and Time Act of 2009 H.R.1796-Residential Carbon Monoxide Poisoning Prevention Act H.R.1998-Health Care Safety Net Enhancement Act of 2009 H.R.3199-Emergency Medic Transition (EMT) Act of 2009 H.R.3360/P.L.111-332-Cruise Vessel Security and Safety Act of 2010 H.R.3590/P.L.111-148-Patient Protection and Affordable Care Act H.R.3596-Health Insurance Industry Antitrust Enforcement Act of 2009 H.R.3962-Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010 H.R.4213-Tax Extenders Act of 2009 H.R.4626-Health Insurance Industry Fair Competition Act H.R.4851-To Provide a Temporary Extension of Certain Programs, and for other purposes H.R.5710-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 H.R.5950-Improving Access to Medicare Coverage Act of 2010 H.R.6306-Critical Care Assessment and Improvement Act of 2010 S.468-Access to Emergency Medical Services Act of 2009 S.1216-Residential Carbon Monoxide Poisoning Prevention Act S.1681-Health Insurance Industry Antitrust Enforcement Act of 2009 S.3575-National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010

Client expense: $589,902 · Firm income: Not reported

Government targets: HOUSE OF REPRESENTATIVES, SENATE

H.R. 1173, the Organized Retail Crime Act of 2008, as related to the prosecution of organized theft. H.R.1166, the E-fencing Enforcement Act of 2008, as related to the prosecution of organized theft. H.R.4011, Organized Retail Crime Prevention and Enforcement Act of 2009, as related to the prosecution of organized theft. S.470, Combating Organized etail Crime Act of 2009, as related to the prosecution of organized theft. H.R.5710, The National All Schedules Electronic Reporting Reauthorization Act. S.3397, Secure and Responsible Drug Disposal Act. H.R.1191, Safe Drug Disposal Act. H.R.5932, Organized Retail Theft Investigation and Prosecution Act. S.3575, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010.

Client expense: $400,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE

HR 5710 - National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 S 256/HR 2923 - Combat Methamphetamine Enhancement Act of 2009 S 3397/ HR 1359 - Secure and Responsible Drug Disposal Act of 2010 S 80 - Pharmaceutical Market Access Act of 2009 HR 1298/S 525 - Pharmaceutical Market Access and Drug Safety Act of 2009 HAMDT 740 (to HR 5822 Military Construction and Veterans Affairs and Related Agencies Appropriations Act, 2010) - a VA prescription drug re-labeling program HR 1204 - The Community Pharmacy Fairness Act of 2009 S 754 - The Methadone Treatment and Protection Act of 2009 HR 2855 - The Drug Overdose Reduction Act HR 163 - Prescription Drug Affordability Act HR 3018 - Amend the Controlled Substance Act to address the use of intrathecal pumps (Docket Number: FDA2010N0184) Agency Information Collection Activities; Proposed Collection; Comment Request; Experimental Study of Patient Information Prototypes (Docket Number: FDA2010N0001) Joint Meeting of the Anesthetic and Life Support Drugs Advisory Committee and the Drug Safety and Risk Management Advisory Committee; Notice of Meeting on Opioid REMS (Docket Number: FDA2010N0168) Developing Guidance on Naming, Labeling, and Packaging Practices to Reduce Medication Errors; Public Workshop; Request for Comments (Docket Number: FDA2010N0128) Prescription Drug User Fee Act; Meetings on Reauthorization; Public Meetings (Docket Number FDA-2010-N-0284 and 2009-D-0461) Risk Evaluation and Mitigation Strategies; Notice of Public Meeting; Reopening of Comment Period (Docket Number: FDA2010N0437) Development and Distribution of Patient Medication Information for Prescription Drugs; Public Hearing (Docket Number: DEA 337N) Dispensing of Controlled Substances at Long-Term Care Facilities; Notice, Solicitation of Information (Docket Number: DEA-339S) Role of Authorized Agents in Communicating Controlled Substance Prescriptions to Pharmacies DEA National Drug Take-Back Day Concept Standardizing REMS programs, components and development of a potential tiered REMS System

Client expense: $212,859 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Drug Enforcement Administration (DEA), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Veterans Affairs, Dept of (VA)

**see addendum page Importation of prescription drugs (S.525/H.R. 1298) RX Pedigree Import Safety (H.R. 759) Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923)) Pharmacy Benefit Management Issues (H.R. 4489) Drug Disposal (S. 3397, H.R. 5809) PDMP Funding/NASPER reauthorization (H.R. 5710)

Client expense: Not reported · Firm income: $60,000

Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE

H.R. 1204, the Community Pharmacy Fairness Act of 2009; H.R. 4489, the FEHBP Prescription Drug Integrity, Transparency and Cost Savings Act of 2010 and working on Senate companion; H.R. 5234, the PBM Audit Reform and Transparency Act of 2010 and working on Senate companion; working with Senate Committee on Health, Education, Labor and pensions on a potential hearing; working with House Committee on Energy and Commerce (health subcommittee) on a potential hearing; worked with the Senate Committee on Aging to provide information for an ongoing committee investigation of certain retail pharmacy practices; H.R. 5235, the Medicare Access to Diabetes Supplies Act of 2010 and working on Senate companion; H.R. 3790, legislation to eliminate the Medicare Part B DME competitive bidding program; submitted statement for the House Committee on Energy and Commerce hearing on the Part B DME competitive bidding program; H.R. 1586, the Education Jobs and Medicaid funding bill, which included an extension of FMAP and change to the AMP definition and became law on 8/10/2010; H.R. 5136 and S. 3454, the FY11 National Defense Authorization Act, includes funding for the Department of Defense and covers the TRICARE pharmacy program; H.R. 3108 and S. 1383, the Medication Therapy Management (MTM) Expanded Benefit Act; worked with Senate offices to gain support for the implemenation of an authpirzed grant program for MTM services; worked with Senate Aging Committee on the issue of nurses as agents in long-term care facilties; H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act of 2010 (NASPER); H.R. 5809, the Safe Drug Disposal Act and S. 3397, the Secure & Responsible Drug Disposal Act (became law 10-12-10); worked with Congressional offices on the issue of Medicare Part B recoupment by CMS; sough Congressional support for the FTC investigation of the merger between a major retail pharmacy chain and a national pharmacy benefit manager (PBM); worked with Congressional offices in seeking clarification from the Department of Treasury regarding the new "over the counter" rules with Flexible Spending Accounts (FSA).

Client expense: $130,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Congressional Budget Office (CBO), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Federal Trade Commission (FTC), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Internal Revenue Service (IRS), Labor, Dept of (DOL), SENATE, Small Business Administration (SBA), Treasury, Dept of

Healthcare Reform: S.391, H.R. 1321 Healthy Americans Act; H.R. 193 American Healthcare Act; H.R. 3200, America's Affordable Health Choices Act; America's Healthy Futures Act of 2009; H.R. 3962, Affordable Healthcare for America Act; H.R. 3590 Patient Protection and Affordable Care Act, Pub. Law No: 111-148 H.R. 5710, National All Schedules Prescription Electronic Reporting Reauthorization Act H.R. 4872, The Health Care and Education Affordability Reconciliation Act of 2010 H.R. 5808, To amend the Patient Protection and Affordable Care Act to establish a public health insurance option. Nondiscrimination language regarding paraprofessionals H.R. 5295, Healthcare Truth and Transparency Act: Healthcare Provider Transparency, Healthcare Provider Misrepresentation H.R. 756, National Pain Care Policy Act, S.660, National Pain Care Policy Act DEA E-Prescribing DEA Propofol Comparative Effectiveness Research Hospital Acquired Infections HITECH Implemenation, Electronic Health Records, Final and Proposed Rules, HIT Meaningful Use Data Registry Funding HHS/OIG Anesthesia Practice Arrangements, Company Model FDA Risk Evaluation and Mitigation Strategies Physician Antitrust Relief Physician Workforce Issues Medical Liability Reform FDA Safe Use Initiative FDA Operating Room Fires FDA ACTION Initiative FDA Propofol Shortage Compliance with Senate Finance Committee request FDA Scheduling of Propofol FDA Sentinel Non-Anesthesia Provider Use of Propofol Prescription Drug User Fee Act Deep sedation NASPER Funding Required Physician Supervision of Nurse Anesthetists, Nurse error rates State Exchanges pursuant to PPACA Patient Safety Initiatives

Client expense: $210,000 · Firm income: Not reported

Government targets: Centers For Medicare and Medicaid Services (CMS), Defense, Dept of (DOD), Drug Enforcement Administration (DEA), Executive Office of the President (EOP), Food & Drug Administration (FDA), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Justice, Dept of (DOJ), Office of Management & Budget (OMB), SENATE

Importation of prescription drugs (S. 525/H.R. 1298); House Energy and Commerce Committee discussion draft; Rx Pedigree; Methamphetamine/Pseudoephedrine Regulation (S. 256/H.R. 2923); Pharmacy Benefit Management (PBM) issues (H.R. 4489); Drug Disposal (S. 3397, H.R. 5809); PDMP Funding/NASPER Reauthorization (H.R. 5710)

Client expense: $270,000 · Firm income: Not reported

Government targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE